<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04775849</url>
  </required_header>
  <id_info>
    <org_study_id>IBSI - 2258/2018</org_study_id>
    <nct_id>NCT04775849</nct_id>
  </id_info>
  <brief_title>Intraoperative Berger Space Imaging (IBSI)</brief_title>
  <acronym>IBSI</acronym>
  <official_title>Intraoperative Berger Space Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigational device is an approved femtosecond laser (FSL) device with an integrated&#xD;
      imaging system to perform certain steps of the cataract procedure. The FSL will perform&#xD;
      anterior capsulotomy and lens fragmentation in individuals suffering from age-related&#xD;
      cataract with need of cataract surgery.&#xD;
&#xD;
      The laser will be reduced to image the Berger space. If not visible, the space will be&#xD;
      enhanced with BSS and Volon A to visualize the BS.&#xD;
&#xD;
      Cataract surgery will be performed in subjects who have signed an informed consent form.&#xD;
      Macula thickness will be measured with Spectralis OCT on screening date.&#xD;
&#xD;
      Postoperative examinations will be implemented in accordance with the approved&#xD;
      investigational plan on subjects and includes: visual acuity, slitlamp examination and&#xD;
      retinal oct imaging.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Cataract surgery will be performed in individuals with age-related cataract.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective is a Berger Space larger than 400μm</measure>
    <time_frame>intraoperative</time_frame>
    <description>The number of patients with visible Berger space and the capacity (volume) of the visible Berger Space will be determined by using the intraoperative OCT recording</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference of central macular thickness between time points</measure>
    <time_frame>Baseline to 1day, 1 week, 3 weeks</time_frame>
    <description>Difference in Central Macular Thickness (CMT) with time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular pressure in different timepoints</measure>
    <time_frame>Baseline to 1day, 1 week, 3 weeks</time_frame>
    <description>Intraocular pressure changes with time.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cataract</condition>
  <condition>Macula Edema</condition>
  <arm_group>
    <arm_group_label>Intraoperative Berger Space Imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative OCT imaging of the space between the posterior capsule and the anterior hyaloid</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond Laser</intervention_name>
    <description>Femtosecond Laser assisted Cataract Surgery will be performed uni- or bilateral</description>
    <arm_group_label>Intraoperative Berger Space Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Bilateral age-related cataract necessitating phacoemulsification extraction and&#xD;
             posterior IOL implantation&#xD;
&#xD;
          -  Age: 40 to 90 (females of childbearing age will be interviewed if pregnancy is&#xD;
             possible)&#xD;
&#xD;
          -  Preoperative pupil size in mydriasis ≥ 6.0 mm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preceding ocular surgery or trauma&#xD;
&#xD;
          -  Pseudoexfoliation&#xD;
&#xD;
          -  Recurrent intraocular inflammation of unknown etiology&#xD;
&#xD;
          -  Uncontrolled glaucoma&#xD;
&#xD;
          -  Uncontrolled systemic or ocular disease&#xD;
&#xD;
          -  Blind fellow eye&#xD;
&#xD;
          -  Microphthalmus&#xD;
&#xD;
          -  Corneal abnormality&#xD;
&#xD;
          -  History of uveitis/iritis&#xD;
&#xD;
          -  Iris neovascularization&#xD;
&#xD;
          -  Proliferative diabetic retinopathy&#xD;
&#xD;
          -  Macular degeneration or any other relevant macular diseases&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rupert Menapace, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Universitiy of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veronika Röggla, MD</last_name>
    <phone>0140400</phone>
    <phone_ext>79450</phone_ext>
    <email>veronika.roeggla@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christina Leydolt, MD</last_name>
    <phone>0140400</phone>
    <phone_ext>79480</phone_ext>
    <email>christina.leydolt@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rupert Menapace, MD</last_name>
      <phone>0140400</phone>
      <phone_ext>66300</phone_ext>
      <email>rupert.menapace@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Christina Leydolt, MD</last_name>
      <phone>0140400</phone>
      <phone_ext>79480</phone_ext>
      <email>christina.leydolt@meduniwien.ac.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>February 26, 2021</last_update_submitted>
  <last_update_submitted_qc>February 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Rupert Menapace</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

